The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1

Journal of Biological Chemistry

Volumn 289, Issue 30, 2014, Pages 21082-21097

  Janes, Kali ^a   Little, Joshua W ^a   Li, Chao ^b   Bryant, Leesa ^a   Chen, Collin ^a   Chen, Zhoumou ^a   Kamocki, Krzysztof ^c   Doyle, Timothy ^a   Snider, Ashley ^d,e   Esposito, Emanuela ^f   Cuzzocrea, Salvatore ^f   Bieberich, Erhard ^g   Obeid, Lina ^d,e   Petrache, Irina ^c   Nicol, Grant ^b   Neumann, William L ^h   Salvemini, Daniela ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pharmacology and Toxicology ^*  (United States)

^c INDIANA UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF MESSINA   (Italy)

^g AUGUSTA UNIVERSITY   (United States)

^h SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2-(4-(5-(3,4-DIETHOXYPHENYL)-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL AMINO)ETHANOL; 3-AMINO-4-(3-HEXYLPHENYLAMINO)-4-OXOBUTYLPHOSPHONIC ACID; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ANILIDE; ANTINEOPLASTIC AGENT; CYTOKINE; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; INDAN DERIVATIVE; LYSOPHOSPHOLIPID; OXADIAZOLE DERIVATIVE; PACLITAXEL; PHOSPHONIC ACID DERIVATIVE; PONESIMOD; PROPANEDIOL DERIVATIVE; S1PR1 PROTEIN, RAT; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE; THIAZOLE DERIVATIVE; THIOPHENE DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; MALE; METABOLISM; NEURALGIA; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYTOKINES; ENZYME ACTIVATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDANS; LYSOPHOSPHOLIPIDS; MALE; NEURALGIA; ORGANOPHOSPHONATES; OXADIAZOLES; PACLITAXEL; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; THIAZOLES; THIOPHENES;

EID: 84905369183     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.569574     Document Type: Article

References (93)

1. Farquhar-Smith, P. (2011) Chemotherapy-induced neuropathic pain. Curr. Opin. Support Palliat. Care 5, 1-7
2. Ogretmen, B., and Hannun, Y. A. (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4, 604-616
3. Spiegel, S., and Milstien, S. (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11, 403-415
4. Rosen, H., and Goetzl, E. J. (2005) Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5, 560-570
5. Adan-Gokbulut, A., Kartal-Yandim, M., Iskender, G., and Baran, Y. (2013) Novel agents targeting bioactive sphingolipids for the treatment of cancer. Curr. Med. Chem. 20, 108-122
6. Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., and Burtin, P. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9, 883-897
7. Welch, S. P., Sim-Selley, L. J., and Selley, D. E. (2012) Sphingosine-1-phosphate receptors as emerging targets for treatment of pain. Biochem. Pharmacol. 84, 1551-1562
8. Salvemini, D., Doyle, T., Kress, M., and Nicol, G. (2013) Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. Trends Pharmacol. Sci. 34, 110-118
9. Zhang, Y. H., and Nicol, G. D. (2004) NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor. Neurosci. Lett. 366, 187-192
10. + current in rat sensory neurons. J. Physiol. 544, 385-402
11. Zhang, Y. H., Vasko, M. R., and Nicol, G. D. (2006) Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons. J. Physiol. 575, 101-113
12. Nicol, G. D. (2008) Nerve growth factor, sphingomyelins, and sensitization in sensory neurons. Sheng Li Xue Bao 60, 603-604
13. Choi, J. I., Svensson, C. I., Koehrn, F. J., Bhuskute, A., and Sorkin, L. S. (2010) Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior. Pain 149, 243-253
14. Doyle, T., Chen, Z., Muscoli, C., Obeid, L. M., and Salvemini, D. (2011) Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-κB- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E2 pathway. FASEB J. 25, 2782-2791
15. Doyle, T., Chen, Z., Obeid, L. M., and Salvemini, D. (2011) Sphingosine-1-phosphate acting via the S1P (1) receptor is a downstream signaling pathway in ceramide-induced hyperalgesia. Neurosci. Lett. 499, 4-8
16. Joseph, E. K., and Levine, J. D. (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci. 20, 2896-2902
17. Mair, N., Benetti, C., Andratsch, M., Leitner, M. G., Constantin, C. E., Camprubí-Robles, M., Quarta, S., Biasio, W., Kuner, R., Gibbins, I. L., Kress, M., and Haberberger, R. V. (2011) Genetic evidence for involvement of neuronally expressed S1P receptor in nociceptor sensitization and inflammatory pain. PLoS One 6, e17268
18. Finley, A., Chen, Z., Esposito, E., Cuzzocrea, S., Sabbadini, R., and Salvemini, D. (2013) Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. PLoS One 8, e55255
19. Patti, G. J., Yanes, O., Shriver, L. P., Courade, J. P., Tautenhahn, R., Manchester, M., and Siuzdak, G. (2012) Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat. Chem. Biol. 8, 232-234
20. Muscoli, C., Doyle, T., Dagostino, C., Bryant, L., Chen, Z., Watkins, L. R., Ryerse, J., Bieberich, E., Neumman, W., and Salvemini, D. (2010) Counterregulation of opioid analgesia by glial-derived bioactive sphingolipids. J. Neurosci. 30, 15400-15408
21. Ndengele, M. M., Cuzzocrea, S., Masini, E., Vinci, M. C., Esposito, E., Muscoli, C., Petrusca, D. N., Mollace, V., Mazzon, E., Li, D., Petrache, I., Matuschak, G. M., and Salvemini, D. (2009) Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitritemediated nitroxidative stress and neuroimmune activation. J. Pharmacol. Exp. Ther. 329, 64-75
22. Yan, X., and Weng, H. R. (2013) Endogenous interleukin-1κ in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-D-aspartic acid receptors. J. Biol. Chem. 288, 30544-30557
23. Ferrier, J., Pereira, V., Busserolles, J., Authier, N., and Balayssac, D. (2013) Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr. Pain Headache Rep. 17, 364
24. Wang, X. M., Lehky, T. J., Brell, J. M., and Dorsey, S. G. (2012) Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 59, 3-9
25. Polomano, R. C., Mannes, A. J., Clark, U. S., and Bennett, G. J. (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94, 293-304
26. Xiao, W. H., Zheng, H., and Bennett, G. J. (2012) Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience 203, 194-206
27. Størkson, R. V., Kjørsvik, A., Tjølsen, A., and Hole, K. (1996) Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods 65, 167-172
28. Bolli, M. H., Abele, S., Binkert, C., Bravo, R., Buchmann, S., Bur, D., Gatfield, J., Hess, P., Kohl, C., Mangold, C., Mathys, B., Menyhart, K., Müller, C., Nayler, O., Scherz, M., Schmidt, G., Sippel, V., Steiner, B., Strasser, D., Treiber, A., and Weller, T. (2010) 2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. J. Med. Chem. 53, 4198-4211
29. Dixon, W. J. (1980) Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 20, 441-462
30. Randall, L. O., and Selitto, J. J. (1957) A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111, 409-419
31. D'Amour, F. E., and Smith, D. L. (1941) A method for determining loss of pain sensation. J. Pharmacol. Exp Ther. 72, 74-79
32. Dobrowsky, R. T., and Kolesnick, R. N. (2001) Analysis of sphingomyelin and ceramide levels and the enzymes regulating their metabolism in response to cell stress. Methods Cell Biol. 66, 135-165
33. Williams, R. D., Wang, E., and Merrill, A. H., Jr. (1984) Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch. Biochem. Biophys. 228, 282-291
34. Little, J. W., Chen, Z., Doyle, T., Porreca, F., Ghaffari, M., Bryant, L., Neumann, W. L., and Salvemini, D. (2012) Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway. J. Neurosci. 32, 10797-10808
35. Youle, M., Osio, M., and ALCAR Study Group (2007) A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med. 8, 241-250
36. Krishnamurthy, K., Dasgupta, S., and Bieberich, E. (2007) Development and characterization of a novel anti-ceramide antibody. J. Lipid Res. 48, 968-975
37. Marvizón, J. C., Chen, W., and Murphy, N. (2009) Enkephalins, dynorphins, and κ-endorphin in the rat dorsal horn: an immunofluorescence colocalization study. J. Comp. Neurol. 517, 51-68
38. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Meth. 9, 671-675
39. Paxinos, G., and Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th Ed., Academic Press, San Diego
40. Angst, D., Janser, P., Quancard, J., Buehlmayer, P., Berst, F., Oberer, L., Beerli, C., Streiff, M., Pally, C., Hersperger, R., Bruns, C., Bassilana, F., and Bollbuck, B. (2012) An oral sphingosine 1-phosphate receptor 1 (S1P (1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation. J. Med. Chem. 55, 9722-9734
41. Itamochi, H., Oishi, T., Shimada, M., Sato, S., Uegaki, K., Naniwa, J., Sato, S., Nonaka, M., Terakawa, N., Kigawa, J., and Harada, T. (2011) Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through up-regulation of c-Jun. Clin. Cancer Res. 17, 4742-4750
42. Dahan, L., Sadok, A., Formento, J. L., Seitz, J. F., and Kovacic, H. (2009) Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines. Br. J. Pharmacol. 158, 610-620
43. Shah, M. R., Kriedt, C. L., Lents, N. H., Hoyer, M. K., Jamaluddin, N., Klein, C., and Baldassare, J. (2009) Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer. J. Exp. Clin. Cancer Res. 28, 84
44. Kriedt, C. L., Baldassare, J., Shah, M., and Klein, C. (2010) Zinc functions as a cytotoxic agent for prostate cancer cells independent of culture and growth conditions. J. Exp. Ther. Oncol. 8, 287-295
45. Doyle, T., Chen, Z., Muscoli, C., Bryant, L., Esposito, E., Cuzzocrea, S., Dagostino, C., Ryerse, J., Rausaria, S., Kamadulski, A., Neumann, W. L., and Salvemini, D. (2012) Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J. Neurosci. 32, 6149-6160
46. Flatters, S. J., and Bennett, G. J. (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122, 245-257
47. Hannun, Y. A., and Obeid, L. M. (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139-150
48. Snider, A. J., Orr Gandy, K. A., and Obeid, L. M. (2010) Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation. Biochimie 92, 707-715
49. Zhang, H., Yoon, S. Y., and Dougherty, P. M. (2012) Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxelinduced painful neuropathy. J. Pain 3, 239-303
50. Zheng, F. Y., Xiao, W. H., and Bennett, G. J. (2011) The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 176, 447-454
51. Delgado, A., Casas, J., Llebaria, A., Abad, J. L., and Fabrias, G. (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim. Biophys. Acta 1758, 1957-1977
52. Sanna, M. G., Wang, S. K., Gonzalez-Cabrera, P. J., Don, A., Marsolais, D., Matheu, M. P., Wei, S. H., Parker, I., Jo, E., Cheng, W. C., Cahalan, M. D., Wong, C. H., and Rosen, H. (2006) Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat. Chem. Biol. 2, 434-441
53. Sanna, M. G., Liao, J., Jo, E., Alfonso, C., Ahn, M. Y., Peterson, M. S., Webb, B., Lefebvre, S., Chun, J., Gray, N., and Rosen, H. (2004) Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279, 13839-13848
54. Verzijl, D., Peters, S. L., and Alewijnse, A. E. (2010) Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implications. Mol. Cells 29, 99-104
55. Gonzalez-Cabrera, P. J., Jo, E., Sanna, M. G., Brown, S., Leaf, N., Marsolais, D., Schaeffer, M. T., Chapman, J., Cameron, M., Guerrero, M., Roberts, E., and Rosen, H. (2008) Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions. Mol. Pharmacol. 74, 1308-1318
56. Bigaud, M., Guerini, D., Billich, A., Bassilana, F., and Brinkmann, V. (2013) Second generation S1P pathway modulators: research strategies and clinical developments. Biochim. Biophys. Acta 1841, 745-758
57. Gonzalez-Cabrera, P. J., Cahalan, S. M., Nguyen, N., Sarkisyan, G., Leaf, N. B., Cameron, M. D., Kago, T., and Rosen, H. (2012) S1P (1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis. Mol. Pharmacol. 81, 166-174
58. Meno-Tetang, G. M., Li, H., Mis, S., Pyszczynski, N., Heining, P., Lowe, P., and Jusko, W. J. (2006) Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl) ethyl]propane-1, 3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab. Dispos. 34, 1480-1487
59. Lin, Y.-Z., Yao, S. Y., Veach, R. A., Torgerson, T. R., and Hawiger, J. (1995) Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255-14258
60. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., and Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632
61. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233
62. Lee, M. K., Han, S. R., Park, M. K., Kim, M. J., Bae, Y. C., Kim, S. K., Park, J. S., and Ahn, D. K. (2011) Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain. Mol. Pain 7, 57
63. Daulhac, L., Mallet, C., Courteix, C., Etienne, M., Duroux, E., Privat, A. M., Eschalier, A., and Fialip, J. (2006) Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Mol. Pharmacol. 70, 1246-1254
64. Jin, S. X., Zhuang, Z. Y., Woolf, C. J., and Ji, R. R. (2003) p38 mitogenactivated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017-4022
65. Chen, Z., Janes, K., Chen, C., Doyle, T., Bryant, L., Tosh, D. K., Jacobson, K. A., and Salvemini, D. (2012) Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J. 26, 1855-1865
66. Brossard, P., Derendorf, H., Xu, J., Maatouk, H., Halabi, A., and Dingemanse, J. (2013) Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study. Br. J. Clin. Pharmacol. 76, 888-896
67. Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., and Cyster, J. G. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355-360
68. Jackson, S. J., Giovannoni, G., and Baker, D. (2011) Fingolimod modulates microglial activation to augment markers of remyelination. J. Neuroinflammation 8, 76
69. Blondeau, N., Lai, Y., Tyndall, S., Popolo, M., Topalkara, K., Pru, J. K., Zhang, L., Kim, H., Liao, J. K., Ding, K., and Waeber, C. (2007) Distribution of sphingosine kinase activity and mRNA in rodent brain. J. Neurochem. 103, 509-517
70. Foster, C. A., Howard, L. M., Schweitzer, A., Persohn, E., Hiestand, P. C., Balatoni, B., Reuschel, R., Beerli, C., Schwartz, M., and Billich, A. (2007) Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J. Pharmacol. Exp. Ther. 323, 469-475
71. Groves, A., Kihara, Y., and Chun, J. (2013) Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J. Neurol. Sci. 328, 9-18
72. Fryer, R. M., Muthukumarana, A., Harrison, P. C., Nodop Mazurek, S., Chen, R. R., Harrington, K. E., Dinallo, R. M., Horan, J. C., Patnaude, L., Modis, L. K., and Reinhart, G. A. (2012) The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P (1)) and hypertension (S1P (3)) in rat. PLoS One 7, e52985
73. Coste, O., Brenneis, C., Linke, B., Pierre, S., Maeurer, C., Becker, W., Schmidt, H., Gao, W., Geisslinger, G., and Scholich, K. (2008) Sphingosine 1-phosphate modulates spinal nociceptive processing. J. Biol. Chem. 283, 32442-32451
74. Coste, O., Pierre, S., Marian, C., Brenneis, C., Angioni, C., Schmidt, H., Popp, L., Geisslinger, G., and Scholich, K. (2008) Antinociceptive activity of the S1P-receptor agonist FTY720. J. Cell. Mol. Med. 12, 995-1004
75. Choi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C. W., Noguchi, K., Teo, S. T., Yung, Y. C., Lu, M., Kennedy, G., and Chun, J. (2011) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl. Acad. Sci. U. S. A. 108, 751-756
76. Peters, C. M., Jimenez-Andrade, J. M., Jonas, B. M., Sevcik, M. A., Koewler, N. J., Ghilardi, J. R., Wong, G. Y., and Mantyh, P. W. (2007) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp. Neurol. 203, 42-54
77. Warwick, R. A., and Hanani, M. (2013) The contribution of satellite glial cells to chemotherapy-induced neuropathic pain. Eur. J. Pain 17, 571-580
78. Burgos, E., Gómez-Nicola, D., Pascual, D., Martín, M. I., Nieto-Sampedro, M., and Goicoechea, C. (2012) Cannabinoid agonist WIN 55, 212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells. Eur. J. Pharmacol. 682, 62-72
79. Gao, M., Yan, X., and Weng, H. R. (2013) Inhibition of glycogen synthase kinase 3κ activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain. Neuroscience 254, 301-311
80. Cata, J. P., Weng, H. R., Lee, B. N., Reuben, J. M., and Dougherty, P. M. (2006) Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol. 72, 151-169
81. Weng, H. R., Aravindan, N., Cata, J. P., Chen, J. H., Shaw, A. D., and Dougherty, P. M. (2005) Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci. Lett. 386, 18-22
82. Ji, R. R., Gereau, R. W., 4th, Malcangio, M., and Strichartz, G. R. (2009) MAP kinase and pain. Brain Res. Rev. 60, 135-148
83. Durafourt, B. A., Lambert, C., Johnson, T. A., Blain, M., Bar-Or, A., and Antel, J. P. (2011) Differential responses of human microglia and bloodderived myeloid cells to FTY720. J. Neuroimmunol. 230, 10-16
84. Daniel, C., Sartory, N., Zahn, N., Geisslinger, G., Radeke, H. H., and Stein, J. M. (2007) FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+regulatory T cells. J. Immunol. 178, 2458-2468
85. Cata, J. P., Weng, H. R., Chen, J. H., and Dougherty, P. M. (2006) Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 138, 329-338
86. Perrotta, C., and Clementi, E. (2010) Biological roles of acid and neutral sphingomyelinases and their regulation by nitric oxide. Physiology 25, 64-71
87. Won, J. S., and Singh, I. (2006) Sphingolipid signaling and redox regulation. Free Radic. Biol. Med. 40, 1875-1888
88. Huwiler, A., and Pfeilschifter, J. (2003) Nitric oxide signalling with a special focus on lipid-derived mediators. Biol. Chem. 384, 1379-1389
89. Nayak, D., Huo, Y., Kwang, W. X., Pushparaj, P. N., Kumar, S. D., Ling, E. A., and Dheen, S. T. (2010) Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 166, 132-144
90. Chi, X. X., and Nicol, G. D. (2010) The sphingosine 1-phosphate receptor, S1PR (1), plays a prominent but not exclusive role in enhancing the excitability of sensory neurons. J. Neurophysiol. 104, 2741-2748
91. Mair, N., Benetti, C., Andratsch, M., Leitner, M. G., Constantin, C. E., Camprubí-Robles, M., Quarta, S., Biasio, W., Kuner, R., Gibbins, I. L., Kress, M., and Haberberger, R. V. (2011) Genetic evidence for involvement of neuronally expressed S1P (1) receptor in nociceptor sensitization and inflammatory pain. PLoS One 6, e17268
92. Bennett, G. J. (2010) Pathophysiology and animal models of cancer-related painful peripheral neuropathy. Oncologist 15, 9-12
93. Paterniti, I., Mazzon, E., Riccardi, L., Galuppo, M., Impellizzeri, D., Esposito, E., Bramanti, P., Cappellani, A., and Cuzzocrea, S. (2012) Peroxisome proliferatoractivated receptor beta/sigma agonist GW0742 ameliorates ceruleinand taurocholate-induced acute pancreatitis in mice. Surgery 152, 90-106